Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete reverse remodelling after aortic valve replacement
Event:
Heart Failure 2023
Topic:
Cardiac Diseases
Session:
ePosters in basic science 2
